About

About Avant Santé Avant Santé Research Center S.A. de C.V., headquartered in Monterrey, Mexico, is a distinguished Contract Research Organization (CRO) committed to revolutionizing Clinical Research by prioritizing Patient-centricity, Quality, and Deliverables. Our philosophy revolves around integrity, honesty, and transparency, instilling trust and confidence among our clients, partners, and study participants. We foster collaborative relationships with sponsors, investigators, regulatory authorities, and patient communities to collectively propel medical science forward. Offering a comprehensive spectrum of services, Avant Santé specializes in everything from Early Phase I first-in-human studies to regulatory services. Our Phase I facility in Monterrey features 80 beds dedicated to healthy human BA/BE studies and 16 beds for early Phase 1 first-in-human studies. This state-of-the-art facility is particularly expert at conducting patient PD studies in asthma patients (methacholine challenge), early Phase 1 first-in-human studies, and healthy human BA/BE studies, adhering to the standards of USFDA, EMA, ANVISA, COFEPRIS, LATAM, and TGA. Avant Santé also provides LATAM regulatory services through its subsidiary, Udela Global, offering a range of services including product dossier preparation, attendance at new molecule committee meetings, facilitation of technical meetings with regulatory agencies, and acting as sponsors' representatives during interactions with regulatory bodies. Avant Santé plays a significant role in late-phase clinical trials (Phase II to IV) focusing on metabolic and liver disorders such as obesity, T2DM, dyslipidemia, MAFLD/MASH, cirrhosis, alcohol hepatitis, PBC, PCOS, HCC, and autoimmune hepatitis. With a site network spanning five LATAM countries and encompassing over 100 sites, we are positioned to make substantial progress in the field of clinical research. Avant Santé also has collaboration with public institutions in Mexico through its Subsidiary EtCurae® for an exclusive access of patient population. EtCurae® is a Site Development & Management Organization for conducting sponsored clinical research, Real-world evidence and Biobanking services in public institutions that have largest patient health care infrastructure and largest patient access in Mexico & Colombia. We focus on developing public health institutions as world class research sites with efficient clinical research infrastructure and capabilities. We simplify Discovery, Pharma, Biotech, Medical device, Nutraceutical, AI based organizations engagement with public health institutions for conducting clinical research. We offer exclusive, sustainable and quick access to research sites with great reach and access to large disease population, today our site network welcomes +190k first time and +441k follow-up patients per year. We operate at national and global quality standards and deliver study start-up timelines in public health institutions as competitive as any other private research sites in the country. Avant Santé Research center contact: Murali Pandela, Chief Scientific Officer and Business Development, mpandela@avantsante.com Mobile: +52 (81)10260090 EtCurae contact: Patricia Campa, Co-Founder & COO, EtCurae pc@etcurae.com Tel +52 5548906495 www.etcurae.com Avant Santé Research Center S.A. de C.V., headquartered in Monterrey, Mexico, is a distinguished Contract Research Organization (CRO) committed to revolutionizing Clinical Research by prioritizing Patient-centricity, Quality, and Deliverables. Our philosophy revolves around integrity, honesty, and transparency, instilling trust and confidence among our clients, partners, and study participants. We foster collaborative relationships with sponsors, investigators, regulatory authorities, and patient communities to collectively propel medical science forward. Offering a comprehensive spectrum of services, Avant Santé specializes in everything from Early Phase I first-in-human studies to regulatory services. Our Phase I facility in Monterrey features 80 beds dedicated to healthy human BA/BE studies and 16 beds for early Phase 1 first-in-human studies. This state-of-the-art facility is particularly expert at conducting patient PD studies in asthma patients (methacholine challenge), early Phase 1 first-in-human studies, and healthy human BA/BE studies, adhering to the standards of USFDA, EMA, ANVISA, COFEPRIS, LATAM, and TGA. Avant Santé also provides LATAM regulatory services through its subsidiary, Udela Global, offering a range of services including product dossier preparation, attendance at new molecule committee meetings, facilitation of technical meetings with regulatory agencies, and acting as sponsors' representatives during interactions with regulatory bodies. Avant Santé plays a significant role in late-phase clinical trials (Phase II to IV) focusing on metabolic and liver disorders such as obesity, T2DM, dyslipidemia, MAFLD/MASH, cirrhosis, alcohol hepatitis, PBC, PCOS, HCC, and autoimmune hepatitis. With a site network spanning five LATAM countries and encompassing over 100 sites, we are positioned to make substantial progress in the field of clinical research. Avant Santé also has collaboration with public institutions in Mexico through its Subsidiary EtCurae® for an exclusive access of patient population. EtCurae® is a Site Development & Management Organization for conducting sponsored clinical research, Real-world evidence and Biobanking services in public institutions that have largest patient health care infrastructure and largest patient access in Mexico & Colombia. We focus on developing public health institutions as world class research sites with efficient clinical research infrastructure and capabilities. We simplify Discovery, Pharma, Biotech, Medical device, Nutraceutical, AI based organizations engagement with public health institutions for conducting clinical research. We offer exclusive, sustainable and quick access to research sites with great reach and access to large disease population, today our site network welcomes +190k first time and +441k follow-up patients per year. We operate at national and global quality standards and deliver study start-up timelines in public health institutions as competitive as any other private research sites in the country. Avant Santé Research center contact: Murali Pandela, Chief Scientific Officer and Business Development, mpandela@avantsante.com Mobile: +52 (81)10260090 EtCurae contact: Patricia Campa, Co-Founder & COO, EtCurae pc@etcurae.com Tel +52 5548906495 www.etcurae.com